Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Clinical Rheumatology|March 20, 2022
Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activitySandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, et al.
Annals of the Rheumatic Diseases|May 5, 2011
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseasesCarla G S Saad, Eduardo F Borba, Nadia E Aikawa, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Advances in Rheumatology (London, England)|June 8, 2023
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this conditionClovis Artur Silva, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, et al.
Lupus|June 4, 2021
Factors associated with neuropsychiatric involvement in Latin American patients with systemic lupus erythematosusLeonor A Barile-Fabris, Hilda Fragoso-Loyo, Daniel Wojdyla, et al.
Annals of the Rheumatic Diseases|March 12, 2022
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseasesNádia Emi Aikawa, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, et al.
Lupus|April 18, 2023
Risk factors for mortality in 1528 Brazilian childhood-onset systemic lupus erythematosus patientsAna P Sakamoto, Clovis A Silva, Ana C Pita, et al.
Pageof 11